Metformin Protects Against Sunitinib-induced Cardiotoxicity: Investigating the Role of AMPK
This study highlights the novel cardioprotective properties of metformin and AMPK activation during sunitinib-induced cardiotoxicity when administered together in the Langendorff heart model.
Source: Journal of Cardiovascular Pharmacology - Category: Cardiology Tags: Original Article Source Type: research
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Fortamet | Heart | Hepatocellular Carcinoma | Leukemia | Liver Cancer | Metformin | Study